Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1995-06-06
1997-01-07
Cintins, Marianne M.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
424449, A61K 3140, A61K 970
Patent
active
055917674
ABSTRACT:
The invention is directed to a patch for the transdermal delivery of the racemic form or the active enantiomer of the analgesic ketorolac. The transdermal patch is capable of delivering therapeutically effective doses of the drug for a period of 12 hours or more. The patch is capable of delivering the racemate of ketorolac at a flux rate of 40 .mu.g/cm.sup.2 .multidot.hr or more, and of the active enantiomer at a flux rate of 20 .mu.g/cm.sup.2 .multidot.hr or more.
REFERENCES:
patent: 3797494 (1974-03-01), Zaffaroni
patent: 4031894 (1977-06-01), Urquhart et al.
patent: 4089969 (1978-05-01), Muchowski et al.
patent: 4460372 (1984-07-01), Campbell et al.
patent: 4588580 (1986-05-01), Gale et al.
patent: 4615699 (1986-10-01), Gale et al.
patent: 4818541 (1989-04-01), Sanderson
patent: 4839174 (1989-06-01), Baker et al.
patent: 4906463 (1990-03-01), Cleary et al.
patent: 4908027 (1990-03-01), Enscore et al.
patent: 4910205 (1990-03-01), Kogan et al.
patent: 4915950 (1990-04-01), Miranda et al.
patent: 4956181 (1990-09-01), Bayer et al.
patent: 4992445 (1991-02-01), Lawter et al.
patent: 5008110 (1991-04-01), Benecke et al.
patent: 5049386 (1991-09-01), Eppstein et al.
patent: 5069909 (1991-12-01), Sharma et al.
patent: 5091182 (1992-02-01), Ong et al.
patent: 5114946 (1992-05-01), Lawter et al.
patent: 5124157 (1992-06-01), Colley et al.
patent: 5519046 (1996-05-01), Noda et al.
Baker, R. W. Controlled Release of Biologically Active Agents, John Wiley & Sons, NY pp. 4-10 (1987).
Jamali et al. J. of Pharmaceutical Sciences 789 695-714 (1989).
Campbell, D. B. European J. of Drug Metabolism and Pharmacokinetics15 109-125 (1990).
Guzman, et al. J. Med. Chem. 29 589-591 (1986).
Mroszczak et al. Clin. Pharmacology & Therapeutics49 126 (1991).
Stinson C&EN46-79 (Sep. 28, 1992).
Yu, et al., "Percutanteous Absorption of Nicardipine and Ketorolac in Rehsus Monkeys," Pharmaceutical Research, vol. 5, No. 7, 1988, pp. 457-462.
Greenwald, "Ketorolac: An Innovative Non-Steroidal Analgesic," Drugs of Today, vol. 28, No. 1, 1992, pp. 41-61.
Pfister, et al., "Permeation Enhancers Compatible with Transdermal Drug Delivery Systems--Part I . . . ," Phar. Tech. Sep. 1990, pp. 132-140.
Brocks et al., Medline AbstractNo. 93092511, 1992.
Baker Richard W.
Mohr Judy M.
Nakaji Lisa A.
Cintins Marianne M.
Jarvis William R. A.
Pharmetrix Corporation
LandOfFree
Liquid reservoir transdermal patch for the administration of ket does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Liquid reservoir transdermal patch for the administration of ket, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Liquid reservoir transdermal patch for the administration of ket will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1764677